John R. Farndon

1.4k total citations
32 papers, 1.0k citations indexed

About

John R. Farndon is a scholar working on Surgery, Nephrology and Epidemiology. According to data from OpenAlex, John R. Farndon has authored 32 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 7 papers in Nephrology and 7 papers in Epidemiology. Recurrent topics in John R. Farndon's work include Neuroendocrine Tumor Research Advances (7 papers), Parathyroid Disorders and Treatments (6 papers) and Pancreatic function and diabetes (5 papers). John R. Farndon is often cited by papers focused on Neuroendocrine Tumor Research Advances (7 papers), Parathyroid Disorders and Treatments (6 papers) and Pancreatic function and diabetes (5 papers). John R. Farndon collaborates with scholars based in United Kingdom, United States and Canada. John R. Farndon's co-authors include Derek Alderson, Jenny Donovan, Jane Blazeby, C. PRYS‐ROBERTS, Samuel A. Wells, William G. Dilley, George S. Leight, Janet K. Dale, Ivan D A Johnston and John Anderson and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Cancer and Diabetes.

In The Last Decade

John R. Farndon

30 papers receiving 965 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John R. Farndon United Kingdom 14 502 303 287 270 252 32 1.0k
Lars‐Erik Tisell Sweden 17 404 0.8× 206 0.7× 258 0.9× 384 1.4× 101 0.4× 23 975
Rupert Prommegger Austria 22 549 1.1× 348 1.1× 290 1.0× 172 0.6× 222 0.9× 45 1.1k
Franco Grimaldi Italy 22 368 0.7× 377 1.2× 377 1.3× 504 1.9× 83 0.3× 65 1.1k
Bohdan Huszno Poland 14 266 0.5× 194 0.6× 143 0.5× 256 0.9× 80 0.3× 61 677
J Barbier France 17 477 1.0× 128 0.4× 202 0.7× 440 1.6× 149 0.6× 46 1.1k
Thomas Clerici Switzerland 14 337 0.7× 325 1.1× 260 0.9× 225 0.8× 55 0.2× 28 703
Cornelia Dotzenrath Germany 17 321 0.6× 152 0.5× 202 0.7× 258 1.0× 92 0.4× 58 796
E Paloyan United States 25 770 1.5× 183 0.6× 285 1.0× 992 3.7× 189 0.8× 63 1.6k
Wai-Fan Chan China 11 630 1.3× 142 0.5× 180 0.6× 585 2.2× 77 0.3× 13 1.0k
C Proye France 13 496 1.0× 92 0.3× 121 0.4× 278 1.0× 191 0.8× 40 744

Countries citing papers authored by John R. Farndon

Since Specialization
Citations

This map shows the geographic impact of John R. Farndon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Farndon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Farndon more than expected).

Fields of papers citing papers by John R. Farndon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Farndon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Farndon. The network helps show where John R. Farndon may publish in the future.

Co-authorship network of co-authors of John R. Farndon

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Farndon. A scholar is included among the top collaborators of John R. Farndon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Farndon. John R. Farndon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stewart, Claire E., et al.. (2002). Selective estrogen receptor modulators inhibit the effects of insulin-like growth factors in hyperparathyroidism. Surgery. 132(6). 998–1007. 11 indexed citations
2.
Farndon, John R., et al.. (2002). Use of octreotide and lanreotide in the treatment of symptomatic non‐resectable carcinoid tumours. ANZ Journal of Surgery. 72(9). 635–638. 18 indexed citations
3.
Fingerhut, Abe, M Schein, & John R. Farndon. (2001). A Surgeon’s Guide to Writing and Publishing. 3 indexed citations
4.
Blazeby, Jane, John R. Farndon, Jenny Donovan, & Derek Alderson. (2000). A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer. 88(8). 1781–1787. 13 indexed citations
5.
Blazeby, Jane, John R. Farndon, Jenny Donovan, & Derek Alderson. (2000). A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer. 88(8). 1781–1787. 238 indexed citations
6.
Wong, Newton A C S, et al.. (2000). Imprint Cytology of Parathyroid Tissue in Relation to Other Tissues of the Neck and Mediastinum. Acta Cytologica. 44(2). 109–113. 9 indexed citations
7.
Mihai, Radu, et al.. (2000). C2-Ceramide Increases Cytoplasmic Calcium Concentrations in Human Parathyroid Cells. Biochemical and Biophysical Research Communications. 268(2). 636–641. 11 indexed citations
8.
9.
Farndon, John R.. (1996). The Oxford Textbook of Surgery. Annals of Surgery. 223(4). 441–441. 3 indexed citations
10.
Farndon, John R.. (1992). Comprehensive Textbook of Oncology, 2nd Edition. Annals of Surgery. 215(3). 294. 14 indexed citations
11.
Farndon, John R.. (1992). Invited commentary. World Journal of Surgery. 16(4). 722–723.
12.
Shenton, B.K., et al.. (1990). DNA analysis and parathyroid pathology. World Journal of Surgery. 14(3). 296–301. 18 indexed citations
13.
Rothmund, Μ., L. Michael Brunt, John R. Farndon, et al.. (1990). Surgery for benign insulinoma: An international review. World Journal of Surgery. 14(3). 393–398. 111 indexed citations
14.
Farndon, John R.. (1989). Essential Surgical Practice, 2nd Ed. Annals of Surgery. 209(3). 375. 25 indexed citations
15.
Walsh, T. N., Derek Alderson, & John R. Farndon. (1987). Dispersed pancreatic graft cryopreservation in the dog: In vivo assessment of preservation protocols. Cryobiology. 24(3). 256–263. 3 indexed citations
16.
Brunt, L. Michael, Johannes D. Veldhuis, William G. Dilley, et al.. (1986). Stimulation of Insulin Secretion by a Rapid Intravenous Calcium Infusion in Patients with β-Cell Neoplasms of the Pancreas*. The Journal of Clinical Endocrinology & Metabolism. 62(1). 210–216. 18 indexed citations
17.
Farndon, John R., et al.. (1983). Histamine and calcitonin release from medullary thyroid carcinoma. Cancer. 51(7). 1221–1225. 1 indexed citations
18.
Farndon, John R., Janet K. Dale, & Samuel A. Wells. (1982). Selective Arteriography Causing Infarction of a Parathyroid Adenoma. Journal of the Royal Society of Medicine. 75(12). 978–980. 1 indexed citations
19.
Cooper, Cary W., et al.. (1981). STIMULATION OF IN VITRO RELEASE OF CALCITONIN FROM RAT AND HUMAN C-CELLS BY CIMETIDINE. Endocrinology. 109(5). 1772–1774. 7 indexed citations
20.
Wells, Samuel A., John R. Farndon, Janet K. Dale, George S. Leight, & William G. Dilley. (1980). Long-term Evaluation of Patients with Primary Parathyroid Hyperplasia Managed by Total Parathyroidectomy and Heterotopic Autotransplantation. Annals of Surgery. 192(4). 451–458. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lars‐Erik Tisell Breakdown of academic impact, for papers by Rupert Prommegger Breakdown of academic impact, for papers by Franco Grimaldi Breakdown of academic impact, for papers by Bohdan Huszno Breakdown of academic impact, for papers by J Barbier Breakdown of academic impact, for papers by Thomas Clerici Breakdown of academic impact, for papers by Cornelia Dotzenrath Breakdown of academic impact, for papers by E Paloyan Breakdown of academic impact, for papers by Wai-Fan Chan Breakdown of academic impact, for papers by C Proye
Rankless by CCL
2026